The researchers cautioned that the findings represent an early stage of biomedical research and require extensive validation before any clinical application becomes possible
News
-
News
-
According to Brihanmumbai Municipal Corporation’s monsoon data for June, July, and August, 441 cases of H1N1, and 4,485 malaria cases were recorded
-
After 15 years of helping people manage their health and fitness, coach Arvind Ashok decided to try a GLP-1 drug for three weeks. It …
-
Scientists are looking for a universal pneumococcal vaccine that can target all the hundred or so forms of Streptococcus pneumonia bacteria, and prevent some …
-
A transplant solves two problems in a single operation: it removes every tumour, eliminates the scarred field that keeps producing them, and restores completely …
-
News
Red hexagon on your snack pack: What FSSAI’s new proposed warning label means | Explained
by AdminThe Food Safety and Standards Authority of India (FSSAI), in an affidavit filed in the Supreme Court on August 28, has proposed that the …
-
A mix of coffee and protein powder, proffee promises caffeine and nutrition in one glass. Experts and fitness enthusiasts weigh in on whether the …
-
To serve our elderly population adequately, we need to know more than simply how many people are eligible for health insurance schemes: we need …
-
ICMR-National Institute of Nutrition (ICMR-NIN), Hyderabad, researchers have found that vitamin D3 is more effective than vitamin D2 in maintaining and restoring muscle and …
-
The GLP-1 drugs semaglutide, sold as Ozempic and Wegovy by Novo Nordisk, and Eli Lilly’s tirzepatide, sold under ‌the brand names Mounjaro and Zepbound, …